Package Leaflet: Information for the User
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Dutasteride Combix is used in men to treat an enlarged prostate(benign prostatic hyperplasia)- a non-cancerous growth of the prostate caused by excessive production of a hormone called dihydrotestosterone.
The active substance is dutasteride. Dutasteride Combix belongs to a group of medications called 5-alpha reductase enzyme inhibitors.
As the prostate grows, it can cause urinary problems such as difficulty in urinating and a need to urinate more frequently. It can also cause the urine stream to be weaker and less forceful. If left untreated, benign prostatic hyperplasia can lead to a risk of the urine flow being completely blocked (acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or remove it. Dutasteride reduces the production of dihydrotestosterone, which helps to reduce the size of the prostate and alleviate symptoms. This reduces the risk of acute urinary retention and the need for surgery.
Dutasteride Combix can also be used with another medication called tamsulosin (used to treat symptoms of an enlarged prostate).
Do not take Dutasteride Combix
Tell your doctorif you think you are in any of these situations.
This medication is only for men. Women, children, and adolescents should not take it.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dutasteride Combix.
Taking Dutasteride Combix with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.
Certain medications may interact with Dutasteride Combix, which can increase the risk of side effects. Some of these medications include:
Tell your doctor if you are taking any of these medications. It may be necessary to reduce the dose of Dutasteride Combix.
Taking Dutasteride Combix with food, drinks, and alcohol
Dutasteride Combix can be taken with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant, breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnant women (or those who may be pregnant) should avoid contact with broken capsules. Dutasteride is absorbed through the skin and may affect the normal development of a male fetus. This risk is especially important during the first 16 weeks of pregnancy.
Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking dutasteride. If your partner is pregnant or may become pregnant, she should avoid exposure to your semen.
Dutasteride Combix has been shown to decrease sperm count, motility, and semen volume, which may reduce fertility.
Consult your doctorif a pregnant woman has been in contact with dutasteride.
Driving and using machines
It is unlikely that Dutasteride Combix will affect your ability to drive or use machines.
Dutasteride Combix contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216), which may cause allergic reactions (possibly delayed).
Follow the instructions for administration of this medication indicated by your doctor or pharmacist exactly.In case of doubt, consult your doctor or pharmacist again.
If you have any further questions on the use of this medication, ask your doctor or pharmacist.
If you take more Dutasteride Combix than you should
If you take too many Dutasteride Combix capsules, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Dutasteride Combix
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
If you stop taking Dutasteride Combix
Do not stop treatment with Dutasteride Combix without consulting your doctor first. It may take up to 6 months or more to notice an effect.
If you have any further questions on the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
Very rare allergic reaction
Symptoms of an allergic reaction can include:
You should contact your doctor immediatelyif you experience any of these symptoms and stop taking Dutasteride Combix.
Common side effects
These can affect up to 1 in 10 men taking dutasteride:
Uncommon side effects
These can affect up to 1 in 100 men taking dutasteride:
Reporting side effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Surveillance System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store above 30°C.
Do not use this medication after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.
Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to a pharmacy or a designated collection point. This will help protect the environment.
Composition of Dutasteride Combix
The other components are: glycerol monocaprylate, butylhydroxytoluene (E321), gelatin, glycerol (E422), methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), titanium dioxide (E171), yellow iron oxide (E172), and purified water.
Appearance of the product and pack contents
Soft gelatin capsules, oblong, yellow, opaque, containing a clear or pale yellow oily liquid.
PVC/PVDC-Aluminum blisters with desiccant and OPA/Aluminum/PVC-Aluminum (standard and perforated). Dutasteride Combix is available in packs of 30 capsules.
Marketing authorization holder and manufacturer
Marketing authorization holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2.
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus France
ZAC Les Hautes Patures
Parc d’activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
Date of last revision of this package leaflet:August 2014
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es.